// App-Quantinova.ai

Mo1242 : Thromboembolic Risk in Hospitalized IBD Patients Is Compounded by Traditional Risk Factors and Hypercoagulable States

Researchers

Presenter

  • Joshua M. Anderson

Principal Investigators

  • Henry Horton

  • Noam Drazin

  • Dermot P. McGovern

  • Gil Y. Melmed

  • Elaine Sun

  • Eric A. Vasiliauskas

  • Marla Dubinsky

  • Phillip Fleshner

  • David Q. Shih

  • Manreet Kaur

  • Andrew Ippoliti

  • Stephan R. Targan

Medical Centers

  • Department of Inflammatory Bowel & Immunobiology Research Institute, Cedars-Sinai Medical Center, Los Angeles, CA

  • Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Inflammatory bowel disease

  • Myocardial infarction

  • Deep vein thrombosis

  • Ulcerative colitis

  • Pulmonary embolism

  • Venous thrombosis

  • Sepsis

  • Stroke

  • Lupus

Biomarkers

  • C reactive protein

  • Estrogen receptor alpha

  • Methylenetetrahydrofolate reductase

Drug/Treatment

  • FVIII

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved